Synapse Medicine: Difference between revisions
Added valuation: Series B+; est. ~€50-100M |
Added cross-references: AIDAVA Competitive Analysis, AIDAVA Related Companies, Lifen |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Company | {{Company | ||
|name=Synapse Medicine | |name=Synapse Medicine | ||
|founded=2017 | |||
|location=Bordeaux, France | |location=Bordeaux, France | ||
|category=Digital Prescription / Medication | |category=Digital Prescription / Medication | ||
| Line 13: | Line 14: | ||
'''Valuation:''' Series B+; est. ~€50-100M | '''Valuation:''' Series B+; est. ~€50-100M | ||
Series B+. Backed by BPI France, Elaia Partners. | Series B+. Backed by BPI France, Elaia Partners. | ||
== Business Details == | |||
* '''Founded:''' 2017 | |||
* '''Total Funding:''' $28M+ | |||
* '''Valuation:''' ~€50-100M (est.) | |||
* '''Revenue:''' N/A (private) | |||
* '''Employees:''' ~50-80 (est.) | |||
* '''Key Milestones:''' $28M raised (TechCrunch reported). Medication intelligence platform. E-prescription safety. | |||
== See Also == | == See Also == | ||
* [[AIDAVA Competitive Analysis]] | |||
* [[AIDAVA Related Companies]] | |||
* [[Lifen]] | |||
* [[France]] | * [[France]] | ||
* [[Digital Prescription]] | * [[Digital Prescription]] | ||
Latest revision as of 17:57, 14 April 2026
What They Do[edit]
Digital prescription and medication management platform helping healthcare professionals prescribe safely and manage drug interactions.
Funding[edit]
Valuation: Series B+; est. ~€50-100M Series B+. Backed by BPI France, Elaia Partners.
Business Details[edit]
- Founded: 2017
- Total Funding: $28M+
- Valuation: ~€50-100M (est.)
- Revenue: N/A (private)
- Employees: ~50-80 (est.)
- Key Milestones: $28M raised (TechCrunch reported). Medication intelligence platform. E-prescription safety.